Meridian Investment Counsel’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,984
Closed -$296K 189
2019
Q3
$296K Hold
2,984
0.16% 134
2019
Q2
$276K Hold
2,984
0.15% 140
2019
Q1
$282K Buy
+2,984
New +$261K 0.16% 132
2018
Q4
Sell
-2,984
Closed -$267K 187
2018
Q3
$267K Hold
2,984
0.15% 142
2018
Q2
$237K Hold
2,984
0.13% 159
2018
Q1
$266K Hold
2,984
0.15% 144
2017
Q4
$311K Hold
2,984
0.17% 134
2017
Q3
$435K Hold
2,984
0.25% 103
2017
Q2
$388K Hold
2,984
0.23% 109
2017
Q1
$371K Sell
2,984
-115
-4% -$13.8K 0.23% 115
2016
Q4
$359K Hold
3,099
0.24% 115
2016
Q3
$324K Hold
3,099
0.22% 119
2016
Q2
$306K Buy
3,099
+857
+38% +$88.6K 0.21% 128
2016
Q1
$224K Hold
2,242
0.16% 144
2015
Q4
$269K Buy
+2,242
New +$259K 0.2% 125

Other funds holding CELG

Meridian Investment Counsel's CELG Position: Q4 2019 in Review

Meridian Investment Counsel sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,984 shares — an estimated $296K sold.

Meridian Investment Counsel first reported a position in CELG in Q4 2015 and held it in 15 quarters. The position peaked at $435K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Meridian Investment Counsel reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Meridian Investment Counsel sold 2,984 Celgene Corp shares in Q4 2019, an estimated $296K.
  • Meridian Investment Counsel first reported a position in Celgene Corp in Q4 2015 and held it in 15 quarters.
  • Meridian Investment Counsel's Celgene Corp position peaked at $435K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Meridian Investment Counsel's 13F filing for Q4 2019, filed 6 Feb 2020.